{
  "url": "https://openlegislation.uk/medicines-for-human-use-clinical-trials-and-blood-safety-and-quality-amendment-regulations-2008/regulation-5",
  "json_url": "https://openlegislation.uk/medicines-for-human-use-clinical-trials-and-blood-safety-and-quality-amendment-regulations-2008/regulation-5.json",
  "legislation": "uksi/2008/941",
  "legislation_title": "The Medicines for Human Use (Clinical Trials) and Blood Safety and Quality (Amendment) Regulations 2008",
  "legislation_url": "https://openlegislation.uk/medicines-for-human-use-clinical-trials-and-blood-safety-and-quality-amendment-regulations-2008",
  "path": "regulation/5",
  "kind": "regulation",
  "number": "5",
  "heading": "Amendment of Schedule 2 to the Clinical Trials Regulations",
  "text": "(1) Schedule 2 to the Clinical Trials Regulations (additional provisions relating to ethics committees) shall be amended as follows.\n(2) In paragraph 1 (interpretation), in the definition of “expert member”, in sub-paragraph (b), for “clinical trials” substitute “clinical research”.\n(3) In paragraph 3 (membership), in sub-paragraph (3), for “Subject to paragraph 7, the” substitute “The”.\n(4) In paragraph 6 (committees, meetings and proceedings)—\n(a) in sub-paragraph (2), for “sub-paragraph (4)” substitute “sub-paragraphs (4) and (4A)”;\n(b) for sub-paragraph (4) substitute the following sub-paragraphs—\n“(4) All valid applications for an ethics committee opinion must be considered by a full meeting of an ethics committee.\n(4A) Where a full meeting of an ethics committee has considered a valid application and reached a provisional opinion, it may delegate the final determination of its opinion in accordance with regulation 15 to the Chairman of the ethics committee or a sub-committee of specified members.”; and\n(c) after sub-paragraph (5) insert the following sub-paragraph—\n“(6) For the purposes of this paragraph, a “full meeting of an ethics committee” is one at which at least seven members of the committee (including any members co-opted under paragraph 8) are present, including at least—\n(a) one lay member who is not and never has been—\n(i) a health care professional, or\n(ii) a chairman, member, director, officer or employee of a health service body; and\n(b) one expert member.”.\n(5) In paragraph 7 (deputies and co-opted members), in sub-paragraph (1), for “An ethics committee” substitute “The appointing authority”.\n(6) In paragraph 8 (co-opted members)—\n(a) in sub-paragraph (3) for “an ethics committee” substitute “a committee that advises or has advised on the ethics of research involving human subjects”; and\n(b) for sub-paragraph (5) substitute the following sub-paragraph—\n“(5) A co-opted member shall hold and vacate office in accordance with the ethics committee’s standing orders and operating procedures adopted under paragraph 6(3).”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2008/941/regulation/5",
    "retrieved_at": "2026-10-29T03:32:28.222096+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}